Dmitry Stakheev, Pavla Taborska, Katerina Kalkusova, Jirina Bartunkova, & Daniel Smrz. (2022). LL-37 as a Powerful Molecular Tool for Boosting the Performance of Ex Vivo-Produced Human Dendritic Cells for Cancer Immunotherapy. MDPI AG.
Chicago Style (17th ed.) CitationDmitry Stakheev, Pavla Taborska, Katerina Kalkusova, Jirina Bartunkova, and Daniel Smrz. LL-37 as a Powerful Molecular Tool for Boosting the Performance of Ex Vivo-Produced Human Dendritic Cells for Cancer Immunotherapy. MDPI AG, 2022.
MLA (9th ed.) CitationDmitry Stakheev, et al. LL-37 as a Powerful Molecular Tool for Boosting the Performance of Ex Vivo-Produced Human Dendritic Cells for Cancer Immunotherapy. MDPI AG, 2022.
Warning: These citations may not always be 100% accurate.